These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18359737)

  • 1. New drugs: nebivolol hydrochloride, nilotinib, and sapropterin dihydrochloride.
    Hussar DA
    J Am Pharm Assoc (2003); 2008; 48(2):315-319. PubMed ID: 18359737
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience of the use of nebivolol in the treatment of hypertension in postmenopausal women].
    Bart BIa; Benevskaia VF; Buval'tsev VI; Boronenkov GM
    Kardiologiia; 2002; 42(8):20-4. PubMed ID: 12494089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebivolol in the management of essential hypertension: a review.
    McNeely W; Goa KL
    Drugs; 1999 Apr; 57(4):633-51. PubMed ID: 10235696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebivolol in obese and non-obese hypertensive patients.
    Manrique C; Whaley-Connell A; Sowers JR
    J Clin Hypertens (Greenwich); 2009 Jun; 11(6):309-15. PubMed ID: 19527321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis.
    Van Bortel LM; Fici F; Mascagni F
    Am J Cardiovasc Drugs; 2008; 8(1):35-44. PubMed ID: 18303936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trial.
    Punzi H; Lewin A; Lukić T; Goodin T; Wei Chen
    Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):349-57. PubMed ID: 21088095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing erectile dysfunction in hypertensive patients.
    Handler J
    J Clin Hypertens (Greenwich); 2011 Jun; 13(6):450-4. PubMed ID: 21649845
    [No Abstract]   [Full Text] [Related]  

  • 9. Nebivolol: a review of its use in the management of hypertension and chronic heart failure.
    Moen MD; Wagstaff AJ
    Drugs; 2006; 66(10):1389-409; discussion 1410. PubMed ID: 16903772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
    Pesant Y; Marc-Aurèle J; Bielmann P; Alaupovic P; Cartier P; Bichet D; Thibault G; Lupien PJ
    Am J Ther; 1999 May; 6(3):137-47. PubMed ID: 10423656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of nebivolol in stage I-II hypertension: a pooled analysis of data from three randomized, placebo-controlled monotherapy trials.
    Weiss RJ; Saunders E; Greathouse M
    Clin Ther; 2011 Sep; 33(9):1150-61. PubMed ID: 21864908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antihypertensive and beta 1-adrenoceptor antagonist effect of nebivolol and atenolol in essential hypertension.
    Simon G; Johnson ML
    Clin Exp Hypertens; 1993 May; 15(3):501-9. PubMed ID: 8098243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension.
    Lefebvre J; Poirier L; Poirier P; Turgeon J; Lacourciere Y
    Br J Clin Pharmacol; 2007 May; 63(5):575-82. PubMed ID: 17094780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of nebivolol on endothelial function in obese patients with hypertension].
    Kovaleva ON; Demidenko AV
    Lik Sprava; 2006 Jun; (4):57-61. PubMed ID: 17100242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebivolol: impact on cardiac and endothelial function and clinical utility.
    Toblli JE; DiGennaro F; Giani JF; Dominici FP
    Vasc Health Risk Manag; 2012; 8():151-60. PubMed ID: 22454559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilating versus first-generation β-blockers for cardiovascular protection.
    Fares H; Lavie CJ; Ventura HO
    Postgrad Med; 2012 Mar; 124(2):7-15. PubMed ID: 22437211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial.
    Lacourcière Y; Lefebvre J; Poirier L; Archambault F; Arnott W
    Am J Hypertens; 1994 Feb; 7(2):137-45. PubMed ID: 8179848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antihypertensive efficacy and tolerability of nebivolol].
    Kirichenko AA; Mironova EV
    Kardiologiia; 2002; 42(12):35-7. PubMed ID: 12494015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of safety and antihypertensive efficacy of a cardioselective beta-blocker nebivolol in patients with hypertension and concomitant chronic obstructive bronchitis].
    Iakushin SS; Okorokov VG; Liferov RA; Fomina VA; Ivanova GO
    Kardiologiia; 2002; 42(11):36-9. PubMed ID: 12494034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.